Associated Papers
Targeted sequencing for hereditary breast and ovarian cancer in BRCA1/2-negative families reveals complex genetic architecture and phenocopies.
Plowman JN et al.
Hgg Advances, 2024
vaRHC: an R package for semi-automation of variant classification in hereditary cancer genes according to ACMG/AMP and gene-specific ClinGen guidelines.
Munté E et al.
Bioinformatics (oxford, England), 2023
Mutational landscape of gastric adenocarcinoma in Latin America: A genetic approach for precision medicine.
Cerrato-Izaguirre D et al.
Genes & Diseases, 2022
CDH1 Germline Variants in a Tunisian Cohort with Hereditary Diffuse Gastric Carcinoma.
Ben Aissa-Haj J et al.
Genes, 2022
Gene panel screening for insight towards breast cancer susceptibility in different ethnicities.
Bishop MR et al.
Plos One, 2020
Frequency of CDH1 germline variants and contribution of dietary habits in early age onset gastric cancer patients in Brazil.
Guindalini RSC et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2019
A pan-cancer analysis of synonymous mutations.
Sharma Y et al.
Nature Communications, 2019
Characterizing Metastatic HER2-Positive Gastric Cancer at the CDH1 Haplotype.
Caggiari L et al.
International Journal of Molecular Sciences, 2017
Sequence-based detection of mutations in cadherin 1 to determine the prevalence of germline mutations in patients with invasive lobular carcinoma of the breast.
Valente AL et al.
Hereditary Cancer in Clinical Practice, 2014
Identification and characterization of CDH1 germline variants in sporadic gastric cancer patients and in individuals at risk of gastric cancer.
Garziera M et al.
Plos One, 2013
Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals.
Kuusisto KM et al.
Breast Cancer Research : Bcr, 2011
CDH1 gene mutations do not contribute in hereditary diffuse gastric cancer in Poland.
Jakubowska A et al.
Familial Cancer, 2010
Mechanisms and sequelae of E-cadherin silencing in hereditary diffuse gastric cancer.
Barber M et al.
The Journal of Pathology, 2008
High incidence of familial gastric cancer in Tuscany, a region in Italy.
Roviello F et al.
Oncology, 2007
E-Cadherin (CDH1) and p53 rather than SMAD4 and Caspase-10 germline mutations contribute to genetic predisposition in Portuguese gastric cancer patients.
Oliveira C et al.
European Journal of Cancer (oxford, England : 1990), 2004
Genetic screening for familial gastric cancer.
Oliveira C et al.
Hereditary Cancer in Clinical Practice, 2004
Genetic screening for hereditary diffuse gastric cancer.
Oliveira C et al.
Expert Review of Molecular Diagnostics, 2003
Screening E-cadherin in gastric cancer families reveals germline mutations only in hereditary diffuse gastric cancer kindred.
Oliveira C et al.
Human Mutation, 2002
Inactivation of the E-cadherin gene in sporadic diffuse-type gastric cancer.
Ascaño JJ et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc, 2001
An efficient and reliable multiplex PCR-SSCP mutation analysis test applied to the human E-cadherin gene.
Berx G et al.
Human Mutation, 1997